Association Between Genetic Polymorphism and Antidepressants in Major Depression: A Network Meta-Analysis

References

• Bromet E , AndradeLH , HwangIet al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med.9, 90 (2011).
   PubMed Web of Science ®Google Scholar
• Malhi GS , MannJJ. Depression. Lancet392(10161), 2299–2312 (2018).
   PubMed Web of Science ®Google Scholar
• Murray CJ , LopezAD. Evidence-based health policy – lessons from the Global Burden of Disease Study. Science274(5288), 740–743 (1996).
   PubMed Web of Science ®Google Scholar
• Kendler KS , PrescottCA , MyersJ , NealeMC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry60(9), 929–937 (2003).
   PubMed Web of Science ®Google Scholar
• Cipriani A , FurukawaTA , SalantiGet al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet391(10128), 1357–1366 (2018).
   PubMed Web of Science ®Google Scholar
• Ozbey G , CelikelFC , CumurcuBEet al. Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder. Nord. J. Psychiatry71(3), 230–237 (2017).
   PubMed Web of Science ®Google Scholar
• Porcelli S , FabbriC , SerrettiA. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur. Neuropsychopharmacol.22(4), 239–258 (2012).
   PubMed Web of Science ®Google Scholar
• Kim H , LimSW , KimSet al. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression. JAMA296(13), 1609–1618 (2006).
   PubMed Web of Science ®Google Scholar
• Andre K , KampmanO , ViikkiMet al. TPH1 A218C polymorphism and temperament in major depression. BMC Psychiatry13, 118 (2013).
   PubMed Web of Science ®Google Scholar
• Savitz J , LuckiI , DrevetsWC. 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol.88(1), 17–31 (2009).
   PubMed Web of Science ®Google Scholar
• Gasso P , RodriguezN , BlazquezAet al. Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine. Prog. Neuropsychopharmacol. Biol. Psychiatry75, 28–34 (2017).
   PubMed Web of Science ®Google Scholar
• Kato M , FukudaT , WakenoMet al. Effects of the serotonin Type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology53(4), 186–195 (2006).
   PubMed Web of Science ®Google Scholar
• Illi A , Setala-SoikkeliE , ViikkiMet al. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport20(12), 1125–1128 (2009).
   PubMed Web of Science ®Google Scholar
• Maruf AA , GreensladeA , ArnoldPD , BousmanC. Antidepressant pharmacogenetics in children and young adults: a systematic review. J. Affect. Disord.254, 98–108 (2019).
   PubMed Web of Science ®Google Scholar
• Sahraian S , BabashamsM , Reza-SoltaniP , NajmabadiH , KahriziK , GorganiSH. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness in Iranian patients with major depressive disorder. Iranian J. Psychiatry8(2), 86–91 (2013).
   PubMedGoogle Scholar
• Zou YF , YeDQ , FengXL , SuH , PanFM , LiaoFF. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur. Neuropsychopharmacol.20(8), 535–544 (2010).
   PubMed Web of Science ®Google Scholar
• Lohoff FW , AquinoTD , NarasimhanS , MultaniPK , EtemadB , RickelsK. Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder. Pharmacogenomics J.13(1), 21–26 (2013).
   PubMed Web of Science ®Google Scholar
• Singh AB , BousmanCA , NgC , BerkM. Antidepressant pharmacogenetics. Curr. Opin. Psychiatry27(1), 43–51 (2014).
   PubMed Web of Science ®Google Scholar
• Kato M , SerrettiA. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry15(5), 473–500 (2010).
   PubMed Web of Science ®Google Scholar
• Taylor MJ , SenS , BhagwagarZ. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol. Psychiatry68(6), 536–543 (2010).
   PubMed Web of Science ®Google Scholar
• Niitsu T , FabbriC , BentiniF , SerrettiA. Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry45, 183–194 (2013).
   PubMed Web of Science ®Google Scholar
• Kao CF , LiuYL , YuYWet al. Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients. Sci. Rep.8(1), 6983 (2018).
   PubMedGoogle Scholar
• Shim S , YoonBH , ShinIS , BaeJM. Network meta-analysis: application and practice using stata. Epidemiol. Health39, e2017047 (2017).
   PubMed Web of Science ®Google Scholar
• Bozina N , PelesAM , SagudM , BilusicH , JakovljevicM. Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder. World J. Biol. Psychiatry9(3), 190–197 (2008).
   PubMed Web of Science ®Google Scholar
• Dogan O , YukselN , ErgunMAet al. Serotonin transporter gene polymorphisms and sertraline response in major depression patients. Genet. Test.12(2), 225–231 (2008).
   PubMedGoogle Scholar
• Hong CJ , ChenTJ , YuYW , TsaiSJ. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J.6(1), 27–33 (2006).
   PubMed Web of Science ®Google Scholar
• Noro M , AntonijevicI , ForrayCet al. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. Int. Clin. Psychopharmacol.25(4), 228–231 (2010).
   PubMed Web of Science ®Google Scholar
• Matsumoto Y , FabbriC , PellegriniSet al. Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder. Mol. Diagn. Ther.18(5), 567–577 (2014).
   PubMed Web of Science ®Google Scholar
• Min W , LiT , MaXet al. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Psychopharmacology205(3), 409–417 (2009).
   PubMed Web of Science ®Google Scholar
• Serretti A , FabbriC , PellegriniSet al. No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression. Psychiatry Investig.10(2), 180–189 (2013).
   PubMed Web of Science ®Google Scholar
• Wilkie MJ , SmithG , DayRKet al. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. Pharmacogenomics J.9(1), 61–70 (2009).
   PubMed Web of Science ®Google Scholar
• Tatham EL , HallGB , ClarkD , FosterJ , RamasubbuR. The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression. Eur. Arch. Psychiatry Clin. Neurosci.267(2), 135–147 (2017).
   PubMed Web of Science ®Google Scholar
• Dong ZQ , LiXR , HeL , HeG , YuT , SunXL. 5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients. Neuropsychiatr. Dis. Treat.12, 1623–1629 (2016).
   PubMed Web of Science ®Google Scholar
• Nishioka G , YashimaH , KiuchiYet al. Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder. Human Psychopharmacol.28(6), 576–585 (2013).
   PubMed Web of Science ®Google Scholar
• Basu A , ChaddaRK , SoodM , KaurH , KukretiR. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: a preliminary study. Indian J. Med. Res.142(1), 40–45 (2015).
   PubMedGoogle Scholar
• Kishi T , YoshimuraR , KitajimaTet al. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. Neuromolecular Med.12(3), 237–242 (2010).
   PubMed Web of Science ®Google Scholar
• Lee SH , ChoiTK , LeeEet al. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine. Neuropsychobiology62(3), 198–206 (2010).
   PubMed Web of Science ®Google Scholar
• Mrazek DA , RushAJ , BiernackaJMet al. SLC6A4 variation and citalopram response. Am. J. Med. Genet. B Neuropsychiatr. Genet.150B(3), 341–351 (2009).
   PubMed Web of Science ®Google Scholar
• Hu XZ , RushAJ , CharneyDet al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch. Gen. Psychiatry64(7), 783–792 (2007).
   PubMed Web of Science ®Google Scholar
• Kang HJ , BaeKY , KimSWet al. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome. J. Affect. Disord.194, 1–8 (2016).
   PubMed Web of Science ®Google Scholar
• Lin JY , JiangMY , KanZM , ChuY. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis. J. Affect. Disord.168, 430–438 (2014).
   PubMed Web of Science ®Google Scholar
• Antypa N , CalatiR , SoueryDet al. Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. J. Affect. Disord.150(2), 649–652 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou C , ZhongJ , ZouBet al. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS ONE12(2), e0172270 (2017).
   PubMed Web of Science ®Google Scholar
• Mcmahon FJ , BuervenichS , CharneyDet al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am. J. Hum. Genet.78(5), 804–814 (2006).
   PubMed Web of Science ®Google Scholar
• Gasso P , BlazquezA , RodriguezNet al. Further support for the involvement of genetic variants related to the serotonergic pathway in the antidepressant response in children and adolescents after a 12-month follow-up: impact of the HTR2A rs7997012 polymorphism. J. Child Adolesc. Psychopharmacol.28(10), 711–718 (2018).
   PubMed Web of Science ®Google Scholar
• Lin E , ChenPS , ChangHHet al. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry33(7), 1167–1172 (2009).
   PubMed Web of Science ®Google Scholar
• Brunoni AR , CarracedoA , AmigoOMet al. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Braz. J. Psychiatry42(2), 128–135 (2019).
   PubMedGoogle Scholar
• Dong C , WongML , LicinioJ. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican–Americans. Mol. Psychiatry14(12), 1105–1118 (2009).
   PubMed Web of Science ®Google Scholar